Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-03-0795
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Novel Mechanism of Attenuation of LPS-Induced NF-κB Activation by the Heat Shock Protein 90 Inhibitor, 17-N-Allylamino-17-Demethoxygeldanamycin, in Human Lung Microvascular Endothelial Cells

American Journal of Respiratory Cell and Molecular Biology
Respiratory MedicinePulmonaryClinical BiochemistryCell BiologyMolecular Biology
2014English

Phase I Pharmacokinetic-Pharmacodynamic Study of 17-(Allylamino)-17-Demethoxygeldanamycin (17AAG, NSC 330507), a Novel Inhibitor of Heat Shock Protein 90, in Patients With Refractory Advanced Cancers

Clinical Cancer Research
Cancer ResearchOncology
2005English

Enhanced Recovery From Contraction-Induced Damage in Skeletal Muscles of Old Mice Following Treatment With the Heat Shock Protein Inducer 17-(Allylamino)-17-Demethoxygeldanamycin

Rejuvenation Research
AgingGerontologyGeriatrics
2008English

Abrogation of Heat Shock Protein 70 Induction as a Strategy to Increase Antileukemia Activity of Heat Shock Protein 90 Inhibitor 17-Allylamino-Demethoxy Geldanamycin

Cancer Research
Cancer ResearchOncology
2005English

Crowding Activates Heat Shock Protein 90

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2016English

Heat Shock Protein 90 (HSP90AA1; Hsp90)

Science-Business eXchange
2009English

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Sulforaphane Potentiates the Efficacy of 17-Allylamino 17-Demethoxygeldanamycin Against Pancreatic Cancer Through Enhanced Abrogation of Hsp90 Chaperone Function

Nutrition and Cancer
MedicineNutritionOncologyCancer ResearchDietetics
2011English

Phase I Study of 17-Allylamino-17 Demethoxygeldanamycin, Gemcitabine and/or Cisplatin in Patients With Refractory Solid Tumors

Investigational New Drugs
OncologyPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy